Peptides
Selank: The Complete Guide to the Anxiolytic Nootropic Peptide
Anxiety disorders affect roughly 300 million people globally, yet conventional pharmacological treatments — benzodiazepines in particular — carry significant risks of dependence, sedation, and cognitive blunting. Researchers and clinicians have long sought alternatives that dampen anxiety without these costs. Selank, a synthetic heptapeptide developed at the Institute of Molecular Genetics of the